Indication
Diffuse proliferative lupus nephritis
Diffuse proliferative lupus nephritis (Class IV lupus nephritis) is a severe, immune-mediated renal complication occurring in patients with systemic lupus erythematosus. Read more about Diffuse proliferative lupus nephritis
57 drugs 51 manufacturers
Drugs that treat it
Common Diffuse proliferative lupus nephritis therapies.
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiffuse proliferative lupus nephritis (Class IV lupus nephritis) is a severe, immune-mediated renal complication occurring in patients with systemic lupus erythematosus.
Defined histopathologically by the involvement of 50 percent or more of glomeruli, it is characterized by widespread endocapillary and mesangial hypercellularity, subendothelial immune complex deposition, and potential crescent formation or fibrinoid necrosis.
Clinically, affected individuals typically present with nephritic syndrome, marked proteinuria, hematuria, hypertension, and a rapid decline in renal function, carrying a substantial risk of progressing to end-stage kidney disease if inadequately managed.
- propath.com
Diffuse proliferative lupus nephritis (Class IV lupus nephritis) is a severe, immune-mediated renal complication occurring in patients with systemic lupus erythematosus
- nih.gov
Diffuse proliferative lupus nephritis (Class IV lupus nephritis) is a severe, immune-mediated renal complication occurring in patients with systemic lupus erythematosus
- ajkdblog.org
Defined histopathologically by the involvement of 50 percent or more of glomeruli, it is characterized by widespread endocapillary and mesangial hypercellularity, subendothelial immune complex deposition, and potential crescent formation or fibrinoid necrosis
- mylupusteam.com
Defined histopathologically by the involvement of 50 percent or more of glomeruli, it is characterized by widespread endocapillary and mesangial hypercellularity, subendothelial immune complex deposition, and potential crescent formation or fibrinoid necrosis Clinically, affected individuals typically present with nephritic syndrome, marked proteinuria, hematuria, hypertension, and a rapid decline in renal function, carrying a substantial risk of progressing to end-stage kidney disease if inadeq...
- promedcert.com
Defined histopathologically by the involvement of 50 percent or more of glomeruli, it is characterized by widespread endocapillary and mesangial hypercellularity, subendothelial immune complex deposition, and potential crescent formation or fibrinoid necrosis Clinically, affected individuals typically present with nephritic syndrome, marked proteinuria, hematuria, hypertension, and a rapid decline in renal function, carrying a substantial risk of progressing to end-stage kidney disease if inadeq...
- nih.gov
Clinically, affected individuals typically present with nephritic syndrome, marked proteinuria, hematuria, hypertension, and a rapid decline in renal function, carrying a substantial risk of progressing to end-stage kidney disease if inadequately managed
Personalize your experience
Follow Diffuse proliferative lupus nephritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.